Christopher A. Haiman

Has grant

University of Southern California
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

ACS IMPACT Research Professorship in Prostate Cancer

Open Date: 2024-07-01

Close Date: 2029-06-30

Articles (28)

Supplementary Table S5 shows results of univariate analysis for 77 chronically elevated serum alanine aminotransferase (cALT)-defined nonalcoholic fatty liver disease in the Pancreatic Cancer Case-Control Consortium (PanC4) data

Year:

2025

Supplementary Table S1 shows results of univariate analysis for 77 chronically elevated serum alanine aminotransferase (cALT)-defined nonalcoholic fatty liver disease SNPs in the Pancreatic Cancer Cohort Consortium (PanScan) data

Year:

2025

Frequencies of all reported germline CHEK2 variant carriers and carriers of variants concordantly categorized by functional our kinase assays in breast cancer patients and controls in 12 analyzed population datasets.

Year:

2025

Supplemental Table 3 shows the associations between adherence to the WCRF/AICR health behavior recommendations and risk of mortality after excluding participants who died within 6, or 12, or 24 months of diagnosis; or those with distant disease at diagnosis; or those with missing data.

Year:

2025

Supplemental Table 1 shows comparisons of characteristics between eligible participants (all those diagnosed with colorectal cancer between enrollment and Q3) and those included in the final study sample.

Year:

2025

Supplemental Figure S2. Meta-analysis full forest plots from AABCG for rs2814778 in relation to risk of breast cancer overall, ER- and TNBC. Figure shows non-significant odds ratio (OR) estimates for breast cancer risk overall, ER- and TNBC for ACKR1/DARC variant, rs2814778 in reference to controls.

Year:

2025

Background: Immune response in blood varies by ancestry, linked to an African-specific variant (rs2814778) in the Duffy Antigen Receptor for Chemokines ( DARC / ACKR1 ) gene. We examined associations between rs2814778, CD8 + T-cell density in breast tumors, and breast cancer risk in African-American/Black women. Methods: CD8 + T-cell density in tumors from 428 Black women were examined in relation to the rs2814778 variant. In the African Ancestry Breast Cancer Genetics (AABCG) Consortium with 16,886 cases and 18,044 controls, rs2814778 was evaluated in relation to risk of overall breast cancer and to more aggressive subtypes [estrogen receptor-negative (ER−) and triple-negative breast cancer (TNBC)]. Results: Women with the African-specific CC genotype had lower tumor CD8 + T-cell density (87.0 per mm 2 ) than those with TT genotypes (146.6 per mm 2 ; P T allele was significantly associated with an increase in T-cell density ( P = 0.04). In the largest analysis, to date, there were no associations between rs2814778 and risk of overall breast cancer [OR = 0.90 (95% confidence interval (CI), 0.66–1.22)] or with ER− breast cancer [OR = 0.86 (95% CI, 0.68–1.08)] or TNBC [OR = 0.77 (95% CI, 0.56–1.05)]. Conclusions: Although breast tumors from women with the African-specific DARC C allele had lower CD8 + T-cell density levels than those with T alleles, in a large breast cancer consortium with adequate statistical power, the variant was not associated with breast cancer risk overall, nor with risk of ER− breast cancer or TNBC, as previously hypothesized. Impact: Although the “Duffy-null” allele has been the focus of research as a contributor to aggressive breast cancer in Black women, this study with 34,930 cases and controls found no associations with risk.

Year:

2025

Supplemental Figure S1. Log-transformed CD8+ T-cell density per mm2 by ACKR1/DARC genotype. Figure displays box plot distribution of CD8+ T-cell density per mm2 according to ACKR1/DARC genotype (N=428).

Year:

2025

Background: Racial and ethnic minority patients with colorectal cancer are underrepresented in studies on health behavior and mortality. Methods: We examined the association between postdiagnosis health behavior and mortality in the Multiethnic Cohort, a diverse group of 215,000 participants from Hawaii and Los Angeles (recruited 1993–1996). Follow-up was through December 31, 2019. Postdiagnosis health behavior was assessed using a modified World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) score (excluding ultraprocessed foods). The primary outcome was overall mortality, and the secondary outcome was colorectal cancer–specific mortality. Results: Among 1,079 eligible participants, 489 (45.3%) were women and 850 (78.8%) self-identified as racially/ethnically minoritized people. Over a median follow-up of 12.2 years, there were 613 all-cause deaths and 105 colorectal cancer–related deaths. The median time from diagnosis to questionnaire completion was 5 years (IQR: 2–8). Higher WCRF/AICR scores (4.5–7) were associated with lower risk of overall mortality compared with lower scores [≤2.25; HR = 0.63; 95% confidence interval (CI), 0.45–0.87]. Risk of colorectal cancer–specific mortality was also lower but not statistically significant. Among individual health behaviors, physical activity was associated with lower risk of all-cause and colorectal cancer–specific mortality (reference: Conclusions: Higher adherence to WCRF/AICR guidelines, particularly engaging in moderate-to-vigorous physical activity, was associated with lower risk of mortality in long-term colorectal cancer survivors. Impact: These findings support the generalizability of prior studies examining adherence to WCRF/AICR guidelines to a broader group of patients with colorectal cancer.

Year:

2025

Background: A substantial portion of the genetic predisposition for breast cancer is explained by multiple common genetic variants of relatively small effect. A subset of these variants, which have been identified mostly in individuals of European (EUR) and Asian ancestries, have been combined to construct a polygenic risk score (PRS) to predict breast cancer risk, but the prediction accuracy of existing PRSs in Hispanic/Latinx individuals (H/L) remain relatively low. We assessed the performance of several existing PRS panels with and without addition of H/L-specific variants among self-reported H/L women. Methods: PRS performance was evaluated using multivariable logistic regression and the area under the ROC curve. Results: Both EUR and Asian PRSs performed worse in H/L samples compared with original reports. The best EUR PRS performed better than the best Asian PRS in pooled H/L samples. EUR PRSs had decreased performance with increasing Indigenous American (IA) ancestry, while Asian PRSs had increased performance with increasing IA ancestry. The addition of two H/L SNPs increased performance for all PRSs, most notably in the samples with high IA ancestry, and did not impact the performance of PRSs in individuals with lower IA ancestry. Conclusions: A single PRS that incorporates risk variants relevant to the multiple ancestral components of individuals from Latin America, instead of a set of ancestry-specific panels, could be used in clinical practice. Impact: The results highlight the importance of population-specific discovery and suggest a straightforward approach to integrate ancestry-specific variants into PRSs for clinical application.

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (132)

Rayjean Hung

University of Toronto

CANADA
View details

Jean Yves Masson

Full Professor

Université Laval Faculté de médecine

CANADA
View details

Neal Freedman

Branch Chief

National Cancer Institute

UNITED STATES
View details

Montserrat Garcia-Closas

Professor of Epidemiology

Institute of Cancer Research

UNITED KINGDOM
View details

Tomáš Zima

Head of Institute

Charles University and General University Hospital in Prague, First Faculty of Medicine

CZECH REPUBLIC
View details

Kathleen Claes

Full professor

Ghent University Hospital

BELGIUM
View details

Giuseppe Matullo

-

ITALY
View details

Lisa Wiesmüller

Professor

Ulm University

GERMANY
View details

Laura Fejerman

Professor

University of California, Davis

UNITED STATES
View details

Andriy Derkach

Associate Attending Biostatistician

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

Christine Ambrosone

Roswell Park Comprehensive Cancer Center

UNITED STATES
View details

Jennifer Hu

Professor

University of Miami

UNITED STATES
View details

Eric Hahnen

-

GERMANY
View details

Susan Domchek

Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES
View details

Sara Lindström

University of Washington

UNITED STATES
View details

Ian M. Thompson

University of Texas Health Science Center at San Antonio

UNITED STATES
View details

Maria Rossing

Associate Clinical Professor

Copenhagen University Hospital

DENMARK
View details

Marco Montagna

Istituto Oncologico Veneto

ITALY
View details

Katherine Nathanson

Professor

University of Pennsylvania

UNITED STATES
View details

Jacques Simard

Full Professor

Laval University

CANADA
View details

Xiao‐Ou Shu

Vanderbilt University Medical Center

UNITED STATES
View details

Nicoletta Resta

Full Professor Medical Genetics

University of Bari Aldo Moro

ITALY
View details

Song Yao

Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES
View details

Maria Piane

Sapienza University of Rome

ITALY
View details

Lynne Wilkens

Professor

University of Hawaii at Manoa

UNITED STATES
View details

Sara González

Institut Català d'Oncologia

SPAIN
View details

Shiv Prakash Verma

Senior Research Scientist

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

FEI CHEN

Assistant Professor

University of Southern California

UNITED STATES
View details

Anne Tjonneland

Professor

Københavns Universitet

DENMARK
View details

June M. Chan

Professor

University of California

UNITED STATES
View details

Katie O'Brien

Staff Scientist

National Institute of Environmental Health Sciences

UNITED STATES
View details

A Heather Eliassen

Professor

Harvard University

UNITED STATES
View details

Irene Ong

Associate Professor

University of Wisconsin-Madison

UNITED STATES
View details

Ulrike Peters

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Song-Yi Park

-

UNITED STATES
View details

Alexandra Martins

INSERM

FRANCE
View details

Stefan Ambs

Senior Investigator (tenured) and Head of the Molecular Epidemiology Section

National Cancer Institute

UNITED STATES
View details

Dale Sandler

Branch Chief

National Institute of Environmental Health Sciences

UNITED STATES
View details

Julie R Palmer

Boston University School of Medicine

UNITED STATES
View details

Clarice Weinberg

Principal Investigator

National Institute of Environmental Health Sciences

UNITED STATES
View details

Alexander E Volk

-

GERMANY
View details

Weang Kee Ho

Professor

Sunway University

MALAYSIA
View details

gaofeng cui

Assistant professor

Mayo Clinic

UNITED STATES
View details

Wei Zheng

-

UNITED STATES
View details

Miquel Porta

-

UNITED STATES
View details

Peter Kraft

Professor

Harvard T.H. Chan School of Public Health

UNITED STATES
View details

Kari Rabe

Assistant Professor of Biostatistics

Mayo Clinic

UNITED STATES
View details

Yara G Abdou

University of North Carolina at Chapel Hill

UNITED STATES
View details

Bizu Gelaye

Chief, Epidemiology Branch and Senior Investigator

Eunice Kennedy Shriver National Institute of Child Health and Human Development

UNITED STATES
View details

Siddhartha Yadav

Associate Professor of Oncology

Mayo Clinic

UNITED STATES
View details

Mariarosaria Calvello

European Institute of Oncology

ITALY
View details

Stephen Chanock

National Institutes of Health

UNITED STATES
View details

Alison Klein

Professor

-

UNITED STATES
View details

Qiuyin Cai

Professor

Vanderbilt University Medical Center

UNITED STATES
View details

anna coppa

Sapienza University of Rome

ITALY
View details

Allison DePersia

NorthShore University HealthSystem

UNITED STATES
View details

Stacey Kenfield

University of California, San Francisco

UNITED STATES
View details

Paul James

Head of Adult Genetics

The Royal Melbourne Hospital Royal Park Campus

AUSTRALIA
View details

Florentia Fostira

National Centre for Scientific Research-Demokritos

GREECE
View details

Paolo Radice

Head of Reserach Unit

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY
View details

Maria Elena. Martinez

University of California

UNITED STATES
View details

Federico Canzian

Group Leader

Deutsches Krebsforschungszentrum

GERMANY
View details

Marketa Janatova

Assistanf Professor and researcher

Přírodovědecká Fakulta, Univerzita Karlova

CZECH REPUBLIC
View details

Herbert Yu

Researcher/Professor

University of Hawaii at Manoa

UNITED STATES
View details

Melissa A. Troester

Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Iona Cheng

University of California

UNITED STATES
View details

Yuan-Ping Pang

Professor of Biophysics and Pharmacology

Mayo Clinic

UNITED STATES
View details

Eva S. Schernhammer

Medical University of Vienna

AUSTRIA
View details

Elad Ziv

Professor

University of California

UNITED STATES
View details

GUOCHONG JIA

Vanderbilt University

UNITED STATES
View details

Martijn C.G.J. Brouwers

-

NETHERLANDS
View details

Andrew Olshan

University of North Carolina at Chapel Hill

UNITED STATES
View details

Gareth Evans

The University of Manchester

UNITED KINGDOM
View details

Esther John

Professor

Stanford University School of Medicine

UNITED STATES
View details

Charles F. Lynch

-

UNITED STATES
View details

Chi-Chen Hong

Associate Professor of Oncology

Roswell Park Comprehensive Cancer Center

UNITED STATES
View details

Weng Khong Lim

Assistant Professor

Duke-NUS Medical School

SINGAPORE
View details

Barbara Pasini

Associate Professor of Medical Genetics

Università degli Studi di Torino

ITALY
View details

Dezheng Huo

University of Chicago

UNITED STATES
View details

Ian Campbell

Group Leader

Peter MacCallum Cancer Institute

AUSTRALIA
View details

Gordon Watt

Junior Group Leader

The Netherlands Cancer Institute

NETHERLANDS
View details

Stacey J. Winham

Mayo Clinic College of Medicine and Science

UNITED STATES
View details

Unnur Valdimarsdottir

Professor

Karolinska Institutet

SWEDEN
View details

Xingyi Guo

Associate Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Jeffrey Weitzel

Professor and Director

University of Kansas Cancer Center

UNITED STATES
View details

Thilo Hackert

University Hospital Heidelberg

GERMANY
View details

Elio Riboli

Professor of Cancer Epidemiology

Imperial College London

UNITED KINGDOM
View details

Rachael Solomon

Senior Eoidemiologist

Division of Cancer Epidemiology and Genetics, National Cancer Institute

UNITED STATES
View details

Luis G Carvajal‐Carmona

Professor

University of California, Davis

UNITED STATES
View details

Jean Wactawki-Wende

Dean, Suny Distinguished Professor

University at Buffalo

UNITED STATES
View details

Jirong Long

Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Malin Sund

Professor/Consultant

University of Helsinki

FINLAND
View details

Banu K. Arun

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Paul Auer

Professor

Medical College of Wisconsin

UNITED STATES
View details

Loic Le Marchand

Professor

University of Hawaii

UNITED STATES
View details

Donghui Li

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Jo Freudenheim

SUNY Distinguished Professor and Associate Dean

University at Buffalo

UNITED STATES
View details

Hoda Anton-Culver

Professor and Chair

University of California, Irvine

UNITED STATES
View details

David Conti

Professor

Colorado School of Public Health

UNITED STATES
View details

Anne Zeleniuch-Jacquotte

Professor of Population Health and Environmental Medicine

NYU School of Medicine

UNITED STATES
View details

Maegan Roberts

Assistant Professor

Ohio State University

UNITED STATES
View details

Alan Arslan

Associate Professor

NYU Langone Medical Center

UNITED STATES
View details

Alvaro Monteiro

Senior Member - Full Professor

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES
View details

Michelle Williams

Professor of Epidemiology

Stanford University

UNITED STATES
View details

Yaohua Yang

Assistant Professor

University of Virginia

UNITED STATES
View details

Corinna Ernst

Hannover Medical School

GERMANY
View details

Nuria Malats

Group Leader

Centro Nacional de Investigaciones Oncológicas

SPAIN
View details

Sarah C. Markt

Case Western Reserve University

UNITED STATES
View details

Kala Visvanathan

Professor

Johns Hopkins University

UNITED STATES
View details

Steven Hart

Mayo Clinic

UNITED STATES
View details

Manal M. Hassan

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Allison W Kurian

Professor

Stanford University School of Medicine

UNITED STATES
View details

Veronica Setiawan

Associate Professor

University of Southern California

UNITED STATES
View details

Jian Gu

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Charles Kooperberg

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Kathryn Ruddy

Professor

Mayo Clinic

UNITED STATES
View details

Olufunmilayo I. Olopade

Professor

University of Chicago

UNITED STATES
View details

Lidia Feliubadaló

Institut Català d'Oncologia

SPAIN
View details

Christopher Li

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Koichi Matsuda

University of Tokyo

JAPAN
View details

Kimberly A. Bertrand

Associate Professor of Medicine

Boston University

UNITED STATES
View details

Bingshan Li

Vanderbilt University

UNITED STATES
View details

Joanne Ngeow

Head

Nanyang Technological University (NTU)

SINGAPORE
View details

Eric Polley

Associate Professor

University of Chicago

UNITED STATES
View details

Elisa Bandera

Chief

Rutgers Cancer Institute of New Jersey

UNITED STATES
View details

Zdenek Kleibl

Laboratory of oncogenetics (head)

Charles University, First Faculty of Medicine

CZECH REPUBLIC
View details

Graham Giles

Head of Research

-

AUSTRALIA
View details

Nicholas Boddicker

Research Associate

Mayo Clinic

UNITED STATES
View details

Amanda Toland

Ohio State University

UNITED STATES
View details

Argyrios Ziogas

Professor

University of California, Irvine

UNITED STATES
View details

Laura Cortesi

University of Modena and Reggio Emilia

ITALY
View details

Manolis Kogevinas

Senior Researcher

Barcelona Institute for Global Health

SPAIN
View details